The phase III, randomized, double-blind, placebo-controlled KEYNOTE-811 study of pembrolizumab plus trastuzumab and chemotherapy for HER2+metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma

Rha S. Y., Kawazoe A., Bai Y., Xu J., Lonardi S., Metges J., ...Daha Fazla

ANNALS OF ONCOLOGY, 2023 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Özet
  • Basım Tarihi: 2023
  • Doi Numarası: 10.1016/j.annonc.2023.10.266
  • Dergi Adı: ANNALS OF ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, CAB Abstracts, EMBASE, MEDLINE
  • Atatürk Üniversitesi Adresli: Evet